Biography

Wu Ke is the Founder and CEO of BravoVax. He has more than 30 years of experiences in biopharm industry and had successfully developed 7 products being approved by CFDA and marketed in China. He also has 30+ applications/granted patents from China or PCT. He was Executive President of Shanghai Zerun Biotechnology, in charge of management of QA/QC, Manufacture, R&D, Engineering and Maintenance, Regulatory Affairs, Marketing, also extensively experienced in business development, technology transfer, etc. Prior to start Zerun, he was Director of R&D in Wuhan Institute of Biological Products, China National Biotec Group (CNBG), in charge of development of new vaccines and blood products. He holds a PhD degree in Immunology, also alumnus of both China Europe International Business School (CEIBS) and Cheung Kong Graduate School of Business (CKGSB). He is a Guest Professor in several universities.

---

Research Interest

His Research interest is in Life science, Pharmaceutical, Biotechnology